Fennec Pharmaceuticals grants 50,000 stock options to three new employees

Filed May 18, 2026 · Period ending May 18, 2026 · ~1 min read

Key Changes

• low

  Fennec granted stock options for 50,000 shares to three new employees under its 2026 Equity Inducement Plan, with an exercise price of $9.75 per share and a ten-year term.

  Item 5.02 verify on EDGAR →
• low

  Options vest over three years: one-third after the first year, then monthly over the following 24 months, contingent on continued employment.

  Item 5.02 verify on EDGAR →
• low

  Grants were made as inducement awards under Nasdaq Listing Rule 5635(c)(4), allowing equity grants outside shareholder-approved plans to attract new hires.

  Item 5.02 verify on EDGAR →